Please enable JavaScript to continue using this application.

Compare $ABUS vs $AUPH | Chartloom

Compare

$ABUS vs $AUPH

Arbutus Biopharma Corp · Aurinia Pharmaceuticals Inc

ABUS

Arbutus Biopharma Corp

AUPH

Aurinia Pharmaceuticals Inc

Compare $ABUS vs $AUPH

Comparing Arbutus Biopharma Corp and Aurinia Pharmaceuticals Inc

ABUSArbutus Biopharma Corp

AUPHAurinia Pharmaceuticals Inc

ABUSArbutus Biopharma Corp

Market cap

$834M

P/E (TTM)

5.44x

Forward P/E (NTM)

—

Forward P/S (NTM)

204.32x

Rev growth (TTM)

1078.8%

YTD performance

-11.5%

52W performance

1.0%

FCF yield

-3.0%

AUPHAurinia Pharmaceuticals Inc

Market cap

$2.14B

P/E (TTM)

7.08x

Forward P/E (NTM)

20.93x

Forward P/S (NTM)

6.14x

Rev growth (TTM)

19.8%

YTD performance

8.5%

52W performance

44.4%

FCF yield

8.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABUS

AUPH

Detailed metrics comparison

ABUS

Arbutus Biopharma Corp

AUPH

Aurinia Pharmaceuticals Inc

Market Cap

ABUS$834M

AUPH$2.14B

Enterprise Value

ABUS$818M

AUPH$2.02B

Price

ABUS$4.22

AUPH$16.65

P/E Ratio

ABUS5.44x

AUPH7.08x

P/S Ratio

ABUS4.59x

AUPH6.87x

EV/Sales

ABUS4.50x

AUPH6.49x

EV/EBITDA

ABUS4.98x

AUPH10.34x

P/B Ratio

ABUS3.41x

AUPH3.43x

P/FCF Ratio

ABUSN/A

AUPH12.23x

EV/FCF

ABUS-33.20x

AUPH11.55x

PEG Ratio

ABUSN/A

AUPH0.02x

Forward P/E (NTM)

ABUSN/A

AUPH20.93x

Forward P/S (NTM)

ABUS204.32x

AUPH6.14x

Revenue (TTM)

ABUS$182M

AUPH$312M

Revenue Growth (YoY)

ABUS1078.8%

AUPH19.8%

Forward Rev Growth

ABUS-97.7%

AUPH17.6%

Gross Margin (TTM)

ABUS0.0%

AUPH90.4%

Operating Margin (TTM)

ABUS82.0%

AUPH48.4%

EBITDA Margin (TTM)

ABUS82.2%

AUPH54.6%

Net Margin (TTM)

ABUS84.2%

AUPH100.8%

FCF Margin (TTM)

ABUS-13.6%

AUPH56.2%

Net Income (TTM)

ABUS$153M

AUPH$314M

FCF (TTM)

ABUS$-25M

AUPH$175M

EPS (TTM)

ABUS$0.78

AUPH$2.35

ROE (TTM)

ABUS91.0%

AUPH59.0%

ROA (TTM)

ABUS82.3%

AUPH45.0%

ROIC (TTM)

ABUS89.2%

AUPH52.4%

Cash

ABUS$19M

AUPH$180M

Debt

ABUS$3M

AUPH$60M

Net Cash/Debt

ABUS$16M

AUPH$119M

Current Ratio (TTM)

ABUS81.42x

AUPH5.42x

Quick Ratio (TTM)

ABUS80.97x

AUPH4.86x

Debt/Equity (TTM)

ABUS0.01x

AUPH0.10x

Debt/Assets (TTM)

ABUS0.0%

AUPH0.0%

Interest Coverage (TTM)

ABUSN/A

AUPHN/A

Net Debt/EBITDA (TTM)

ABUS0.00x

AUPH0.00x

Beta

ABUS0.79

AUPH1.35

52W Performance

ABUS1.0%

AUPH44.4%

YTD Performance

ABUS-11.5%

AUPH8.5%

% from 52W High

ABUS-22.6%

AUPH-13.5%

% from 52W Low

ABUS20.6%

AUPH52.7%

Asset Turnover (TTM)

ABUS0.98x

AUPH0.45x

FCF Yield (TTM)

ABUS-3.0%

AUPH8.2%

Earnings Yield (TTM)

ABUS18.4%

AUPH14.7%

Dividend Yield (TTM)

ABUSN/A

AUPHN/A

Rule of 40

ABUS1,065.2

AUPH76.0

EV/GP/RG

ABUSN/A

AUPH0.52

Ticker research

View ABUS research View AUPH research

Metric	ABUS Arbutus Biopharma Corp	AUPH Aurinia Pharmaceuticals Inc
Market & Valuation
Market Cap	$834M	$2.14B
Enterprise Value	$818M	$2.02B
Price	$4.22	$16.65
P/E Ratio	5.44x	7.08x
P/S Ratio	4.59x	6.87x
EV/Sales	4.50x	6.49x
EV/EBITDA	4.98x	10.34x
P/B Ratio	3.41x	3.43x
P/FCF Ratio	N/A	12.23x
EV/FCF	-33.20x	11.55x
PEG Ratio	N/A	0.02x
Forward P/E (NTM)	N/A	20.93x
Forward P/S (NTM)	204.32x	6.14x
Revenue & Growth
Revenue (TTM)	$182M	$312M
Revenue Growth (YoY)	1078.8%	19.8%
Forward Rev Growth	-97.7%	17.6%
Profitability
Gross Margin (TTM)	0.0%	90.4%
Operating Margin (TTM)	82.0%	48.4%
EBITDA Margin (TTM)	82.2%	54.6%
Net Margin (TTM)	84.2%	100.8%
FCF Margin (TTM)	-13.6%	56.2%
Net Income (TTM)	$153M	$314M
FCF (TTM)	$-25M	$175M
EPS (TTM)	$0.78	$2.35
ROE (TTM)	91.0%	59.0%
ROA (TTM)	82.3%	45.0%
ROIC (TTM)	89.2%	52.4%
Financial Health
Cash	$19M	$180M
Debt	$3M	$60M
Net Cash/Debt	$16M	$119M
Current Ratio (TTM)	81.42x	5.42x
Quick Ratio (TTM)	80.97x	4.86x
Debt/Equity (TTM)	0.01x	0.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	1.35
52W Performance	1.0%	44.4%
YTD Performance	-11.5%	8.5%
% from 52W High	-22.6%	-13.5%
% from 52W Low	20.6%	52.7%
Efficiency & Yields
Asset Turnover (TTM)	0.98x	0.45x
FCF Yield (TTM)	-3.0%	8.2%
Earnings Yield (TTM)	18.4%	14.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,065.2	76.0
EV/GP/RG	N/A	0.52
Ticker research	View ABUS research	View AUPH research

Valuation

P/E Ratio

ABUS

5.44x

AUPH

7.08x

P/S Ratio

ABUS

4.59x

AUPH

6.87x

EV/FCF

ABUS

-33.20x

AUPH

11.55x

Growth & revenue

Revenue Growth TTM

ABUS

1078.8%

AUPH

19.8%

Forward Revenue Growth

AUPH

17.6%

ABUS

-97.7%

Profitability & performance

Gross Margin

AUPH

90.4%

ABUS

0.0%

ROE

ABUS

91.0%

AUPH

59.0%

FCF Yield %

AUPH

8.2%

ABUS

-3.0%

52-Week Performance

AUPH

44.4%

ABUS

1.0%

Detailed metrics comparison

ABUS

Arbutus Biopharma Corp

AUPH

Aurinia Pharmaceuticals Inc

Market Cap

ABUS$834M

AUPH$2.14B

Enterprise Value

ABUS$818M

AUPH$2.02B

Price

ABUS$4.22

AUPH$16.65

P/E Ratio

ABUS5.44x

AUPH7.08x

P/S Ratio

ABUS4.59x

AUPH6.87x

EV/Sales

ABUS4.50x

AUPH6.49x

EV/EBITDA

ABUS4.98x

AUPH10.34x

P/B Ratio

ABUS3.41x

AUPH3.43x

P/FCF Ratio

ABUSN/A

AUPH12.23x

EV/FCF

ABUS-33.20x

AUPH11.55x

PEG Ratio

ABUSN/A

AUPH0.02x

Forward P/E (NTM)

ABUSN/A

AUPH20.93x

Forward P/S (NTM)

ABUS204.32x

AUPH6.14x

Revenue (TTM)

ABUS$182M

AUPH$312M

Revenue Growth (YoY)

ABUS1078.8%

AUPH19.8%

Forward Rev Growth

ABUS-97.7%

AUPH17.6%

Gross Margin (TTM)

ABUS0.0%

AUPH90.4%

Operating Margin (TTM)

ABUS82.0%

AUPH48.4%

EBITDA Margin (TTM)

ABUS82.2%

AUPH54.6%

Net Margin (TTM)

ABUS84.2%

AUPH100.8%

FCF Margin (TTM)

ABUS-13.6%

AUPH56.2%

Net Income (TTM)

ABUS$153M

AUPH$314M

FCF (TTM)

ABUS$-25M

AUPH$175M

EPS (TTM)

ABUS$0.78

AUPH$2.35

ROE (TTM)

ABUS91.0%

AUPH59.0%

ROA (TTM)

ABUS82.3%

AUPH45.0%

ROIC (TTM)

ABUS89.2%

AUPH52.4%

Cash

ABUS$19M

AUPH$180M

Debt

ABUS$3M

AUPH$60M

Net Cash/Debt

ABUS$16M

AUPH$119M

Current Ratio (TTM)

ABUS81.42x

AUPH5.42x

Quick Ratio (TTM)

ABUS80.97x

AUPH4.86x

Debt/Equity (TTM)

ABUS0.01x

AUPH0.10x

Debt/Assets (TTM)

ABUS0.0%

AUPH0.0%

Interest Coverage (TTM)

ABUSN/A

AUPHN/A

Net Debt/EBITDA (TTM)

ABUS0.00x

AUPH0.00x

Beta

ABUS0.79

AUPH1.35

52W Performance

ABUS1.0%

AUPH44.4%

YTD Performance

ABUS-11.5%

AUPH8.5%

% from 52W High

ABUS-22.6%

AUPH-13.5%

% from 52W Low

ABUS20.6%

AUPH52.7%

Asset Turnover (TTM)

ABUS0.98x

AUPH0.45x

FCF Yield (TTM)

ABUS-3.0%

AUPH8.2%

Earnings Yield (TTM)

ABUS18.4%

AUPH14.7%

Dividend Yield (TTM)

ABUSN/A

AUPHN/A

Rule of 40

ABUS1,065.2

AUPH76.0

EV/GP/RG

ABUSN/A

AUPH0.52

Ticker research

View ABUS research View AUPH research

Metric	ABUS Arbutus Biopharma Corp	AUPH Aurinia Pharmaceuticals Inc
Market & Valuation
Market Cap	$834M	$2.14B
Enterprise Value	$818M	$2.02B
Price	$4.22	$16.65
P/E Ratio	5.44x	7.08x
P/S Ratio	4.59x	6.87x
EV/Sales	4.50x	6.49x
EV/EBITDA	4.98x	10.34x
P/B Ratio	3.41x	3.43x
P/FCF Ratio	N/A	12.23x
EV/FCF	-33.20x	11.55x
PEG Ratio	N/A	0.02x
Forward P/E (NTM)	N/A	20.93x
Forward P/S (NTM)	204.32x	6.14x
Revenue & Growth
Revenue (TTM)	$182M	$312M
Revenue Growth (YoY)	1078.8%	19.8%
Forward Rev Growth	-97.7%	17.6%
Profitability
Gross Margin (TTM)	0.0%	90.4%
Operating Margin (TTM)	82.0%	48.4%
EBITDA Margin (TTM)	82.2%	54.6%
Net Margin (TTM)	84.2%	100.8%
FCF Margin (TTM)	-13.6%	56.2%
Net Income (TTM)	$153M	$314M
FCF (TTM)	$-25M	$175M
EPS (TTM)	$0.78	$2.35
ROE (TTM)	91.0%	59.0%
ROA (TTM)	82.3%	45.0%
ROIC (TTM)	89.2%	52.4%
Financial Health
Cash	$19M	$180M
Debt	$3M	$60M
Net Cash/Debt	$16M	$119M
Current Ratio (TTM)	81.42x	5.42x
Quick Ratio (TTM)	80.97x	4.86x
Debt/Equity (TTM)	0.01x	0.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.79	1.35
52W Performance	1.0%	44.4%
YTD Performance	-11.5%	8.5%
% from 52W High	-22.6%	-13.5%
% from 52W Low	20.6%	52.7%
Efficiency & Yields
Asset Turnover (TTM)	0.98x	0.45x
FCF Yield (TTM)	-3.0%	8.2%
Earnings Yield (TTM)	18.4%	14.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,065.2	76.0
EV/GP/RG	N/A	0.52
Ticker research	View ABUS research	View AUPH research